Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shugang Qin

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Acta Pharmaceutica Sinica. B|March 27, 2023
Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccineXing Duan, Yi Zhang, Mengran Guo, et al.
Immunology|April 14, 2022
cGAS modulates cytokine secretion and bacterial burdens by altering the release of mitochondrial DNA in pseudomonas pulmonary infectionBiao Wang, Chuanmin Zhou, Qun Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2021
Gut Microbiota Regulate Gut-Lung Axis Inflammatory Responses by Mediating ILC2 Compartmental MigrationQinqin Pu, Ping Lin, Pan Gao, et al.
Biomaterials|January 6, 2026
Harnessing the death switch: Empowering cancer therapy by modulating the apoptosis-pyroptosis transitionYan Chen, Jie Wang, Quan Dai, et al.
Advanced Functional Materials|August 9, 2022
mRNA Vaccines Against SARS-CoV-2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable LipidsKepan Chen, Na Fan, Hai Huang, et al.
Nature Communications|August 21, 2019
High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho terminationPing Lin, Qinqin Pu, Qun Wu, et al.
Molecular Cell|April 30, 2020
CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian CellsPing Lin, Shugang Qin, Qinqin Pu, et al.
Acta Pharmaceutica Sinica. B|January 17, 2023
A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variantsShugang Qin, Hai Huang, Wen Xiao, et al.
Journal of Nanobiotechnology|March 30, 2024
Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumanniiXing Lan, Shugang Qin, Huan Liu, et al.
Journal of Nanobiotechnology|May 28, 2024
Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infectionYupei Zhang, Songhui Zhai, Hai Huang, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Acta Pharmaceutica Sinica. B|March 27, 2023
Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccineXing Duan, Yi Zhang, Mengran Guo, et al.
Immunology|April 14, 2022
cGAS modulates cytokine secretion and bacterial burdens by altering the release of mitochondrial DNA in pseudomonas pulmonary infectionBiao Wang, Chuanmin Zhou, Qun Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2021
Gut Microbiota Regulate Gut-Lung Axis Inflammatory Responses by Mediating ILC2 Compartmental MigrationQinqin Pu, Ping Lin, Pan Gao, et al.
Biomaterials|January 6, 2026
Harnessing the death switch: Empowering cancer therapy by modulating the apoptosis-pyroptosis transitionYan Chen, Jie Wang, Quan Dai, et al.
Advanced Functional Materials|August 9, 2022
mRNA Vaccines Against SARS-CoV-2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable LipidsKepan Chen, Na Fan, Hai Huang, et al.
Nature Communications|August 21, 2019
High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho terminationPing Lin, Qinqin Pu, Qun Wu, et al.
Molecular Cell|April 30, 2020
CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian CellsPing Lin, Shugang Qin, Qinqin Pu, et al.
Acta Pharmaceutica Sinica. B|January 17, 2023
A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variantsShugang Qin, Hai Huang, Wen Xiao, et al.
Journal of Nanobiotechnology|March 30, 2024
Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumanniiXing Lan, Shugang Qin, Huan Liu, et al.
Journal of Nanobiotechnology|May 28, 2024
Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infectionYupei Zhang, Songhui Zhai, Hai Huang, et al.
Pageof 5